TI
JAZZ icon

Trexquant Investment’s Jazz Pharmaceuticals JAZZ Stock Holding History

Trexquant Investment’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,287
Closed -$1.24M – 1900
2025
Q4 		$1.24M Buy
+7,287
New +$1.12M 0.01% 1117
2025
Q2 		– Sell
-64,078
Closed -$7.96M – 1714
2025
Q1 		$7.96M Buy
64,078
+14,781
+30% +$1.93M 0.09% 329
2024
Q4 		$6.07M Buy
49,297
+10,090
+26% +$1.19M 0.07% 452
2024
Q3 		$4.37M Buy
+39,207
New +$4.3M 0.06% 528
2024
Q2 		– Sell
-58,864
Closed -$7.09M – 1691
2024
Q1 		$7.09M Buy
58,864
+2,257
+4% +$276K 0.14% 202
2023
Q4 		$6.96M Buy
+56,607
New +$7.06M 0.16% 163
2023
Q3 		– Sell
-10,549
Closed -$1.31M – 1639
2023
Q2 		$1.31M Sell
10,549
-6,686
-39% -$900K 0.03% 668
2023
Q1 		$2.52M Buy
17,235
+176
+1% +$26K 0.07% 376
2022
Q4 		$2.72M Sell
17,059
-594
-3% -$87.1K 0.08% 329
2022
Q3 		$2.35M Buy
+17,653
New +$2.68M 0.08% 311
2022
Q2 		– Sell
-6,330
Closed -$985K – 1681
2022
Q1 		$985K Buy
+6,330
New +$919K 0.05% 477
2019
Q1 		– Sell
-35,234
Closed -$4.37M – 1136
2018
Q4 		$4.37M Buy
+35,234
New +$5.23M 0.27% 100
2017
Q3 		– Sell
-1,600
Closed -$249K – 902
2017
Q2 		$249K Buy
+1,600
New +$245K 0.07% 563
2016
Q4 		– Sell
-2,300
Closed -$279K – 1045
2016
Q3 		$279K Buy
+2,300
New +$310K 0.06% 507
2016
Q2 		– Sell
-9,200
Closed -$1.2M – 974
2016
Q1 		$1.2M Sell
9,200
-9,300
-50% -$1.16M 0.14% 233
2015
Q4 		$2.6M Buy
18,500
+12,200
+194% +$1.69M 0.23% 98
2015
Q3 		$836K Buy
6,300
+3,300
+110% +$568K 0.07% 492
2015
Q2 		$528K Buy
+3,000
New +$539K 0.06% 593

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Trexquant Investment's JAZZ Position: Q1 2026 in Review

Trexquant Investment sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 7,287 shares — an estimated $1.24M sold.

Trexquant Investment first reported a position in JAZZ in Q2 2015 and held it in 18 quarters. The position peaked at $7.96M in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Trexquant Investment reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Trexquant Investment sold 7,287 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.24M.
  • Trexquant Investment first reported a position in Jazz Pharmaceuticals in Q2 2015 and held it in 18 quarters.
  • Trexquant Investment's Jazz Pharmaceuticals position peaked at $7.96M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.